Preparation method of non-transition metal-catalyzed 2-halogenated pyridine compound
A halogenated pyridine and metal-catalyzed technology, which is applied in the field of preparation of pharmaceutical and chemical intermediates, can solve the problems of narrow substrate range, high reaction temperature, and harsh reaction conditions, and achieve great use value, social and economic benefits, and broad market prospects , the effect of easy access to raw materials
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] Example 1: Synthesis of 2-chloroquinoline (2a)
[0038]
[0039] Weigh quinoline-2-carboxylic acid (51.9mg, 0.3mmol), sodium carbonate (16.0mg, 0.15mmol), NaCl (26.3mg, 0.45mmol), tert-butyl hypochlorite (102μL, 0.9mmol) into 25mL Schlenk reaction flask, then add CH 2 Cl 2 (2 mL) was placed in an oil bath at 60°C for 5 h. After the reaction was completed, the solvent was removed under reduced pressure, and petroleum ether / ethyl acetate was used as the eluent, and the silica gel column was used for separation. The yield of 2-chloroquinoline was 82%.
[0040] 1 H NMR (400MHz, CDCl 3 ):δ8.06(d, J=8.6Hz, 1H), 8.00(d, J=8.5Hz, 1H), 7.78(d, J=8.1Hz, 1H), 7.75–7.67(m, 1H), 7.53 (t,J=7.5Hz,1H),7.34(d,J=8.6Hz,1H); 13 C NMR (100MHz, CDCl 3 ): δ150.6, 147.9, 138.9, 130.6, 128.6, 127.6, 127.0, 126.8, 122.3.
Embodiment 2
[0041] Embodiment 2: Synthesis of 2-chloropyridine (2b)
[0042]
[0043]Weigh pyridine-2-carboxylic acid (36.9mg, 0.3mmol), potassium carbonate (4.2mg, 0.03mmol), NCS (60.1mg, 0.45mmol), tert-butyl hypochlorite (68μL, 0.6mmol) into 25mL of Schlenk reaction vial, then add CH 2 Cl 2 (2 mL) was placed in an oil bath at 150°C for 10 h. After the reaction, the solvent was removed under reduced pressure, and petroleum ether / ethyl acetate was used as the eluent, and silica gel column separation was performed. The yield of 2-chloropyridine was 68%.
[0044] 1 H NMR (400MHz, CDCl3): δ8.40 (dd, J = 4.8, 1.8Hz, 1H), 7.66 (td, J = 7.7, 2.0 Hz, 1H), 7.34 (d, J = 8.0Hz, 1H), 7.23(ddd,J=7.3,4.9,0.7Hz,1H); 13 C NMR (100 MHz, CDCl3): δ151.61, 149.81, 138.69, 124.47, 122.23.
Embodiment 3
[0045] Embodiment 3: Synthesis of 2-chloro-3-phenylpyridine (2c)
[0046]
[0047] Weigh 3-phenylpyridine-2-carboxylic acid (56.7mg, 0.3mmol), sodium carbonate (32.0mg, 0.3mmol), NaCl (26.3mg, 0.45mmol), TBHP (102μL, 0.9mmol) into 25mL of Schlenk reaction bottle, then added THF (2 mL) and placed in an oil bath at 80°C for 20 h. After the reaction was completed, the solvent was removed under reduced pressure, and petroleum ether / ethyl acetate was used as the eluent, and silica gel column separation was performed. The yield of 2-chloropyridine was 91%. 1 H NMR (400MHz, CDCl3): δ8.38(s, 1H), 7.80–7.57(m, 1H), 7.44(d, J=5.7Hz, 5H), 7.29(dd, J=11.4, 6.6Hz, 1H ); 13 C NMR (100MHz, CDCl 3 ): δ149.7, 148.4, 139.7, 137.5, 137.0, 129.3, 128.4, 122.6.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


